The progress of histopathology reporting

Jo Horne, Andrew Usher and Gerry van Schalkwyk discuss the progress of the histopathology reporting programme and look to the future.

Molecular mechanisms of parkinson's

Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson’s disease.

MRI for prostate cancer screening?

A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately.

"Cancer survivors have increased risk"

Survivors of childhood cancer are at increased risk of suffering prematurely from cardiovascular disease in adulthood, says a new study.

My lab: the cancer biomarkers team

Ruth Riisnaes gives a guided tour of her lab at the Institute of Cancer Research in Sutton.

Digital pathology for the NHS

The government has announced that it is in discussion with Roche Diagnostics and partners to support the mainstream implementation of Digital Pathology services across the NHS.

NHS workforce boost planned

Health Education England (HEE) has published a long-awaited plan for how to tackle staffing issues in NHS cancer services.

Diagnosing with holograms

Could 3D imaging developments from the US change the way that diagnostic tests are carried out?

Consent training: a biomedical scientist perspective

Senior Biomedical Scientist Olivia Geling discusses a consent training day she attended and outlines the key messages.

Histopathology reporting survey results

Brian Nation analyses the figures and draws out the trends from a survey of biomedical scientists on histopathology reporting training. 

Histopathology reporting: IBMS and RCPath statement

The IBMS and Royal College of Pathologists have come together to produce “The Role of Biomedical Scientists in Histopathology Reporting: A Joint Statement from the Royal College of Pathologists and Institute of Biomedical Science”.